OneMedNet Expands Network to 90M Patient Journeys, 270M Studies

  • OneMedNet's iRWD™ Network now includes 90 million patient journeys and 270 million studies, up 12.5% since April 2026.
  • Healthcare partner network grew 30% in under a year, reaching 2,300 sites.
  • Specialized data coverage expanded across radiology, cardiology, EEG, ECG, and rare diseases.
  • CEO Aaron Green emphasized network expansion as a core pillar of long-term value creation.

OneMedNet's milestone reflects a strategic focus on expanding its data network, aligning with broader industry trends toward AI-driven healthcare innovation. The company's ability to curate diverse, multi-modal data positions it as a key player in meeting the needs of life sciences organizations and drug developers. The rapid growth in patient journeys and studies underscores the increasing reliance on Real-World Data for medical breakthroughs and AI advancements.

Data Demand
How accelerating demand for Real-World Data and AI foundational models will impact OneMedNet's growth trajectory.
Network Scalability
Whether OneMedNet can sustain its rapid expansion of healthcare partner sites and data coverage.
Competitive Positioning
The pace at which OneMedNet can differentiate itself in the competitive landscape of AI-driven healthcare data.